(Q46795537)

25 December 2017

title

Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs. (English)

1 reference

25 December 2017

1 reference

Katsuyoshi Sugimoto

1

1 reference

25 December 2017

Tsukasa Uno

series ordinal

2

1 reference

25 December 2017

Tomonori Tateishi

series ordinal

3

1 reference

25 December 2017

publication date

1 June 2008

1 reference

25 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

25 December 2017

volume

64

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

583-587

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-008-0461-2

exact match

0 references

cites work

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0461-2

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

21 January 2018

1 reference

12 December 2020

Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population

1 reference

12 December 2020

Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay

1 reference

12 December 2020

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

12 December 2020

Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of [...]

1 reference

12 December 2020

Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam

1 reference

12 December 2020

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

1 reference

12 December 2020

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

1 reference

12 December 2020

Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes

1 reference

12 December 2020

Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects

1 reference

12 December 2020

Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4

1 reference

12 December 2020

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

1 reference

12 December 2020

Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism

1 reference

12 December 2020

CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir

1 reference

12 December 2020

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers

1 reference

12 December 2020

Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype

1 reference

12 December 2020

Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population

1 reference

12 December 2020

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

12 December 2020

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients

1 reference

12 December 2020

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

12 December 2020

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation

1 reference

12 December 2020

Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.

1 reference

12 December 2020

Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.

1 reference

12 December 2020

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

1 reference

12 December 2020

Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults

1 reference

12 December 2020

Significance of the minor cytochrome P450 3A isoforms.

1 reference

12 December 2020

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

1 reference

12 December 2020

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

12 December 2020

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

1 reference

12 December 2020

10.1007/S00228-008-0461-2

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017